Orchid Cellmark
Orchid Cellmark is a UK-based provider of DNA relationship-testing and forensic laboratory services.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Orchid Cellmark is a DNA testing and forensic services company whose roots date to the commercial development of DNA fingerprinting in the United Kingdom. Cellmark was established in 1987 by ICI after the company licensed DNA fingerprinting technology developed by Alec Jeffreys at the University of Leicester. Its early purpose was to turn specialist genetic identification methods into practical testing services, particularly for parentage and other biological-relationship questions. The company received a Queen's Award for Technological Achievement in 1990, reflecting the significance of its work in applying DNA science outside academic research. Cellmark became the first private paternity-testing company in the United Kingdom. It subsequently developed a broader role in regulated relationship testing, including work connected with immigration and visa applications and paternity testing carried out for the Child Support Agency. The company also participated in consultations that contributed to the Department of Health's voluntary code of practice for genetic paternity testing in England, Wales and Northern Ireland. This placed the business within an emerging framework in which laboratory accreditation, chain of custody, consent, interpretation and reporting standards were important to the credibility of DNA evidence. The company passed through several corporate owners. Following ICI's 1993 demerger, Cellmark became part of Zeneca and later AstraZeneca after the 1998 merger that created AstraZeneca. In 2001 it was acquired by Orchid BioSciences Inc., a Princeton, New Jersey-based biotechnology company. Orchid BioSciences later adopted the Orchid Cellmark name and operated DNA laboratories in Germantown, Dallas and Nashville, Tennessee. The UK business was registered as Orchid Cellmark Ltd in 2005, linking the established Cellmark operation with its American parent and expanding the brand's corporate identity across the Atlantic. Laboratory Corporation of America Holdings, commonly known as LabCorp, completed its acquisition of Orchid Cellmark Inc. in December 2011. During the LabCorp period, the business continued to provide relationship-testing and forensic capabilities. In 2015, it acquired Keith Borer Consultants, a Durham-based provider of forensic defence services, through wholly owned OCM Acquisition Corp. The acquisition broadened the organisation's position beyond laboratory testing into services supporting forensic defence work. In the United States, the former Orchid Cellmark operation became known as Cellmark Forensics, Inc. The UK management team acquired Orchid Cellmark Ltd from LabCorp in 2018. The company continued operating as an independent specialist provider, with laboratories in Abingdon-on-Thames, Oxfordshire, and Chorley, Lancashire. Its UK activities include accredited DNA relationship testing and forensic services for police and other justice-sector users. The organisation has been described as one of the major forensic-service providers to police forces in England and Wales. Its work depends on laboratory quality systems, evidential integrity and the ability to produce results suitable for legal, immigration, family and criminal-investigation contexts. On 20 August 2024, Cellmark was acquired by Eurofins Scientific. This placed the business within a large international laboratory-services group while preserving Cellmark's specialist identity in DNA and forensic testing. The brand's history therefore spans academic technology licensing, specialist private testing, ownership by major life-science and laboratory companies, management ownership, and eventual integration into Eurofins. Its principal differentiation is the combination of relationship testing with forensic laboratory and investigative support rather than consumer genetic ancestry services.
History
Orchid Cellmark originated as Cellmark, a specialist DNA-testing business established by ICI in 1987. ICI licensed DNA fingerprinting technology developed by Alec Jeffreys at the University of Leicester, enabling the company to commercialise a scientific method that had previously been associated primarily with academic research. Cellmark focused on practical DNA identification and relationship testing and received a Queen's Award for Technological Achievement in 1990. The company became the first private paternity-testing provider in the United Kingdom. It developed services for paternity and other biological-relationship questions, including testing performed for the Child Support Agency and accredited testing used in immigration and visa applications. Cellmark also contributed to consultations associated with the Department of Health's voluntary code of practice for genetic paternity testing in England, Wales and Northern Ireland. These activities helped establish expectations around accreditation, consent, evidence handling and the presentation of genetic results. After ICI's 1993 demerger, Cellmark became part of Zeneca and then AstraZeneca following the 1998 formation of AstraZeneca. In 2001, Orchid BioSciences Inc. acquired the company. Orchid BioSciences was based in Princeton, New Jersey, and later changed its name to Orchid Cellmark Inc. Under this ownership the organisation operated laboratories in Germantown, Dallas and Nashville, Tennessee. The UK operation was registered as Orchid Cellmark Ltd in 2005. LabCorp completed the acquisition of Orchid Cellmark Inc. in December 2011. The business retained its focus on DNA relationship testing and forensic services. In 2015, it expanded its forensic capabilities by acquiring Keith Borer Consultants, a Durham-based provider of forensic defence services, through its wholly owned subsidiary OCM Acquisition Corp. The US operation subsequently became known as Cellmark Forensics, Inc. In 2018, Orchid Cellmark Ltd was acquired from LabCorp by its management team. The UK company continued to operate specialist laboratories in Abingdon-on-Thames, Oxfordshire, and Chorley, Lancashire. It became a significant supplier of forensic services to police forces in England and Wales, while continuing to offer accredited relationship-testing services. The company's work spans family and immigration matters, criminal investigations and forensic defence. On 20 August 2024, Cellmark was acquired by Eurofins Scientific. The transaction marked the latest ownership change in a history that began with ICI, continued through Zeneca and AstraZeneca, and later included Orchid BioSciences, LabCorp and management ownership. Across these changes, the Cellmark identity has remained associated with specialist DNA analysis, accredited relationship testing and forensic laboratory support.
- 2024
Acquired by Eurofins Scientific
[1]Cellmark is acquired by Eurofins Scientific on 20 August 2024.
- 2018
Management buyout from LabCorp
[1]The management team acquires Orchid Cellmark Ltd from LabCorp.
- 2015
Acquires Keith Borer Consultants
[1]The company acquires Keith Borer Consultants through OCM Acquisition Corp., adding forensic defence services.
- 2011
Acquired by LabCorp
[1]Laboratory Corporation of America Holdings completes the acquisition of Orchid Cellmark Inc.
- 2005
UK company registered as Orchid Cellmark Ltd
[1]The UK operation is registered under the Orchid Cellmark Ltd name.
- 2001
Acquired by Orchid BioSciences
[1]Orchid BioSciences Inc. acquires Cellmark and later adopts the Orchid Cellmark name.
- 1998
Moves into AstraZeneca
[1]Cellmark becomes part of AstraZeneca following the creation of that group.
- 1993
Becomes part of Zeneca
[1]Following ICI's demerger, Cellmark becomes part of Zeneca.
- 1990
Queen's Award for Technological Achievement
[1]Cellmark receives a Queen's Award recognising its technological work in applying DNA testing.
- 1987
Cellmark is established by ICI
[1]ICI establishes Cellmark after licensing DNA fingerprinting technology developed by Alec Jeffreys at the University of Leicester.
Products and positioning
A specialist, accreditation-led provider of DNA relationship and forensic services for legal, government, immigration, police and defence users.
Relationship testing
DNA relationship testing
Accredited DNA testing used to establish biological relationships, including paternity and other family relationships. The service has supported private, legal, government and immigration-related cases, where laboratory accreditation and documented evidence handling are important to the reliability and acceptability of results.
Relationship testing
Paternity testing
Paternity testing was one of Cellmark's foundational services and made the company the first private paternity-testing provider in the United Kingdom. The business has also carried out paternity testing for the Child Support Agency and participated in discussions concerning standards for genetic paternity testing.
Immigration testing
Immigration and visa DNA testing
Accredited DNA relationship testing supporting immigration and visa applications. These cases require testing and reporting practices suitable for submission to government or immigration authorities, rather than informal consumer genetic analysis.
Forensic services
Forensic DNA services
Laboratory and specialist forensic services supporting criminal investigations and police forces. The offering is associated with the analysis of DNA evidence and the production of results intended for use within formal investigative and legal processes.
Forensic services · 2015
Forensic defence services
Forensic support for defence work, strengthened by the 2015 acquisition of Keith Borer Consultants through OCM Acquisition Corp. The activity complements laboratory testing with specialist services for forensic defence cases.
Controversies
Brand decisions
2024
Eurofins Scientific acquires CellmarkM&ABackground
Cellmark had become a major provider of forensic services to police forces in England and Wales while retaining relationship-testing capabilities.
Action taken
Eurofins Scientific acquired Cellmark on 20 August 2024.
Aftermath
Cellmark became part of the Eurofins group, while the specialist brand and its DNA and forensic-service focus continued.
2018
Management acquisition from LabCorpM&ABackground
After several changes in corporate ownership, the UK business continued operating as a specialist DNA and forensic-services provider.
Action taken
The Orchid Cellmark Ltd management team acquired the company from LabCorp.
Aftermath
The company operated independently with UK laboratories in Abingdon-on-Thames and Chorley until its acquisition by Eurofins Scientific in 2024.
2015
Acquisition of Keith Borer ConsultantsM&ABackground
Orchid Cellmark sought to extend its specialist forensic capabilities beyond laboratory testing.
Action taken
The company acquired Keith Borer Consultants through its wholly owned subsidiary OCM Acquisition Corp.
Aftermath
The acquisition added forensic defence services based in Durham to the wider Cellmark offering.
2011
LabCorp acquires Orchid CellmarkM&ABackground
Orchid Cellmark operated DNA laboratories and provided relationship-testing and forensic services in the United Kingdom and United States.
Action taken
Laboratory Corporation of America Holdings completed the acquisition of Orchid Cellmark Inc. in December 2011.
Aftermath
The business continued under LabCorp ownership until the UK operation was acquired by its management team in 2018.
2001
Orchid BioSciences acquires CellmarkM&ABackground
Cellmark had developed a specialist position in DNA relationship testing and forensic services under earlier ICI, Zeneca and AstraZeneca ownership.
Action taken
Orchid BioSciences Inc. acquired Cellmark and subsequently used the Orchid Cellmark identity.
Aftermath
The business became part of a US-based biotechnology group and operated laboratories in both the United Kingdom and the United States.
Recent events
- 2024
Eurofins Scientific acquires Cellmark[1]
M&A
Cellmark was acquired by Eurofins Scientific on 20 August 2024, placing the DNA and forensic-services business within the Eurofins group.
- 2018
Orchid Cellmark acquired by its management team[1]
M&A
The management team of Orchid Cellmark Ltd acquired the UK company from LabCorp and continued its operation as an independent specialist business.
- 2015
Keith Borer Consultants acquired[1]
M&A
Orchid Cellmark acquired Durham-based Keith Borer Consultants through OCM Acquisition Corp., extending its activities into forensic defence services.
- 2011
LabCorp completes acquisition of Orchid Cellmark[1]
M&A
Laboratory Corporation of America Holdings completed its acquisition of Orchid Cellmark Inc. in December 2011.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/orchid-cellmark · Editorial policy · How profiles are compiled